glp 1 derived from GLP-1 Agonists - What is it? GLP-1 Receptor Agonists as Treatments
Description
As the graphic illustrates, the index for new prescriptions in 2023 was 104, thus four points above the 100 mark
Includes 0 g Added Sugars 0 g 0%
The Medicines and Healthcare products Regulatory Agency (MHRA) has warned healthcare professionals to be aware of the potential risk of pulmonary aspiration in patients using glucagon-like peptide-1 (GLP-1) or dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonists (GLP-1 RAs), who undergo surgery or procedures with general anaesthesia or deep sedation
Easy to download and print
